-
John Daniel O'Sullivan, MD
… in movement disorders research. He has led and coordinated multiple clinical trials in Parkinson's disease and has over … therapy in some patients. Dr. O'Sullivan currently oversees multiple research projects on non-motor symptoms in …
-
Martin E. Sanders, MD
… research, patient care, senior officer positions at multiple companies, venture capital partnership, and membership on multiple for-profit and non-profit boards. He is a …
-
Support for your Collaboration on Proof-of-concept clinical trial on the use of the 5-HT1A/1B Partial Agonist Eltoprazine for Treatment of L-DOPA-induced Dyskinesias. - Linked to Bjorklund CIA 2009
… fewer and fewer dopamine terminals survive, another neuron system kicks in: the serotonin neurons. The serotonin … transmitter,” but in a non-physiological manner. Studies in multiple pre-clinical models of the disease have shown that …
-
Novel Fumarate Esters as Neuroprotective Agents in Parkinson’s Disease
… immuno-modulatory and neuroprotective effects in cell-based systems, pre-clinical models of disease and clinical trials in multiple sclerosis and psoriasis patients. The biological …
-
LRRK2 Variation in Parkinson's Disease
… have also been the driving force behind disease-model systems and the directed the therapeutic intervention … variant. We will also assess the possible role of multiple LRRK2 variants acting together to result in disease …
-
Lorene Nelson, PhD, MS
… disease, amyotrophic lateral sclerosis (ALS) and multiple sclerosis. The primary objectives of Dr. Nelson's … Dr. Nelson is a scientific advisor to the National Multiple Sclerosis Society and the Amyotrophic Lateral …